1. Home
  2. ABTS vs AWH Comparison

ABTS vs AWH Comparison

Compare ABTS & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABTS
  • AWH
  • Stock Information
  • Founded
  • ABTS 2010
  • AWH 1993
  • Country
  • ABTS Hong Kong
  • AWH United States
  • Employees
  • ABTS N/A
  • AWH N/A
  • Industry
  • ABTS Computer Software: Programming Data Processing
  • AWH Medical/Dental Instruments
  • Sector
  • ABTS Technology
  • AWH Health Care
  • Exchange
  • ABTS Nasdaq
  • AWH Nasdaq
  • Market Cap
  • ABTS 15.8M
  • AWH 13.5M
  • IPO Year
  • ABTS N/A
  • AWH N/A
  • Fundamental
  • Price
  • ABTS $0.44
  • AWH $0.78
  • Analyst Decision
  • ABTS
  • AWH Buy
  • Analyst Count
  • ABTS 0
  • AWH 2
  • Target Price
  • ABTS N/A
  • AWH $4.40
  • AVG Volume (30 Days)
  • ABTS 12.9K
  • AWH 60.0K
  • Earning Date
  • ABTS 11-27-2024
  • AWH 11-11-2024
  • Dividend Yield
  • ABTS N/A
  • AWH N/A
  • EPS Growth
  • ABTS N/A
  • AWH N/A
  • EPS
  • ABTS N/A
  • AWH N/A
  • Revenue
  • ABTS $5,343,888.00
  • AWH $8,923,000.00
  • Revenue This Year
  • ABTS N/A
  • AWH $15.59
  • Revenue Next Year
  • ABTS N/A
  • AWH $108.47
  • P/E Ratio
  • ABTS N/A
  • AWH N/A
  • Revenue Growth
  • ABTS 3970.67
  • AWH N/A
  • 52 Week Low
  • ABTS $0.38
  • AWH $0.74
  • 52 Week High
  • ABTS $1.60
  • AWH $6.01
  • Technical
  • Relative Strength Index (RSI)
  • ABTS 43.70
  • AWH 40.31
  • Support Level
  • ABTS $0.41
  • AWH $0.76
  • Resistance Level
  • ABTS $0.52
  • AWH $0.89
  • Average True Range (ATR)
  • ABTS 0.04
  • AWH 0.07
  • MACD
  • ABTS -0.00
  • AWH 0.01
  • Stochastic Oscillator
  • ABTS 26.58
  • AWH 33.92

About ABTS Abits Group Inc

Abits Group Inc is a digital data center operator with bitcoin self-mining operations.

About AWH Aspira Women's Health Inc.

Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.

Share on Social Networks: